-
CSR Summary Not Available
-
NCT00236600
-
Primary Citation
-
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNutritional and Metabolic DiseasesEnrollment561% Female76%% White98%
Product ClassAnticonvulsantsSponsor Protocol NumberTOPMAT-OBES-004Data PartnerJohnson & JohnsonCondition StudiedObesityMean/Median Age (Years)43.8
Supporting Documentation
- Collected Datasets Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available